Rounds with Investigators 2012 | Breast #3
Rounds with the Investigators 2012 | Breast Cancer
QUESTION: What do you do with a woman in her late eighties or nineties, very vigorous, with a HER2-positive tumor? This is coming up fairly frequently.
DR HAROLD BURSTEIN: With regard to the 90-year-old, I would treat her very gently, and maybe a little touch of paclitaxel/trastuzumab, as we’ve talked about for some of our other low-risk patients, and see how she does.
DR SARA HURVITZ: Would you use vinorelbine?
DR BURSTEIN: I could. Sure.
DR LOVE: Is there an age limit to your T-DM1 adjuvant trial coming up?
Clinical Controversies in the Management of Metastatic Colorectal Cancer
Consensus or Controversy: Clinical Investigators Provide Their Perspectives on Practical Issues and Research Questions in the Management of Non-Small Cell Lung Cancer
These audio proceedings from an Independent Satellite Symposium held at the 2012 ASCO Annual meeting offer the perspectives of 5 renowned international clinical investigators on a number of controversial management and research issues.
This content is available in a number of formats for listening on the go with a mobile device or at home on a computer.
Audio Highlights of Challenging Cases in Multiple Myeloma: Oncologist and Nurse Investigators Consult on Actual Patients from the Practices of the Invited Faculty
In these audio proceedings from a symposium held in conjunction with the Oncology Nursing Society's 2012 Annual Congress, the invited oncology nursing professionals participating as part of our faculty panel present actual patient cases from their practices, setting the stage for faculty discussion of optimal therapeutic and supportive care strategies in multiple myeloma.
This content is available in a number of formats for listening on the go with a mobile device or in the office or at home on a computer.
Select Publications
Select Publications
Attal M et al. Maintenance treatment with lenalidomide after transplantation for myeloma: Analysis of secondary malignancies within the IFM 2005-02 trial. Proc International Myeloma Workshop 2011. Abstract
Davies FE et al. Are there benefits to long-term bisphosphonate treatment in multiple myeloma (MM)? Insights from temporal analyses of zoledronic acid (ZOL) versus clodronate (CLO) in the MRC Myeloma IX trial. Proc ASCO 2011;Abstract 8011.
RTP TV 2012 – Colorectal Cancer
RTP TV 2012: A Live CME Webcast Series Focused on Emerging Data Sets and Novel Therapeutic Strategies in the Management of Common Cancers
RTP TV 2012: A Live CME Webcast Series Focused on Emerging Data Sets and Novel Therapeutic Strategies in the Management of Common Cancers
Using a fast-moving and conversational approach devoid of didactic presentations, this webcast series was designed to profile the people, papers and concepts that are shaping current clinical decision-making in a number of important cancer types. Each archived episode features 2 expert faculty members reviewing recent data, discussing challenging cases and responding to audience questions.
Click below to view any of the recorded video proceedings from the RTP TV webcast series. These CME activities feature video, PowerPoint and related web links.
Survey Says: A Grand Rounds Activity Focused on Real Cases of Patients with Non-Small Cell Lung Cancer
Survey Says: A Grand Rounds Activity Focused on Real Cases of Patients with Colorectal Cancer
Breast Cancer Tumor Board: Clinical Investigators Discuss Actual Patients from Their Practices
What the Second Opinion Experiences of Clinical Investigators Tell Us About the Current Management of Non-Hodgkin Lymphomas and Multiple Myeloma
60-year-old woman: 1.8-cm, ER/PR-positive, HER2-positive, Grade II IDC with 1 of 3 sentinel nodes positive for disease
60-year-old woman: 1.8-cm, ER/PR-positive, HER2-positive,
Grade II IDC with 1 of 3 sentinel nodes positive for disease
National Patterns of Care Study of Clinical Investigators and Practicing Oncologists
Practice Patterns Among Webcast Viewers
RTP TV 2012 - HER2+ Breast Cancer